DUBLIN–( COMPANY CABLE)– The “Antisense and RNAi Therapies – Worldwide Strategic Company Record” record has actually been contributed to ResearchAndMarkets.com’s offering. The worldwide market for Antisense and RNAi Therapies was approximated at US$ 2.1 Billion in 2023 and is forecasted to get to US$ 3.6 Billion by 2030, expanding at a CAGR of 8.1% from 2023 to 2030. This extensive record offers a thorough evaluation of market fads, chauffeurs, and projections, aiding you make educated company choices. The expand
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/antisense-and-rnai-therapeutics-market-research-report-2023-2030-expanding-use-in-chronic-and-inflammatory-diseases-drives-long-term-market-opportunities-researchandmarkets-com/
